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Abstract
Background: Factors that regulate intracellular calcium concentration are known to play a critical
role in brain function and neural development, including neural plasticity and neurogenesis. We
previously demonstrated that the neurosteroid allopregnanolone (APα; 5α-pregnan-3α-ol-20-one)
promotes neural progenitor proliferation in vitro in cultures of rodent hippocampal and human
cortical neural progenitors, and in vivo in triple transgenic Alzheimer's disease mice dentate gyrus.
We also found that APα-induced proliferation of neural progenitors is abolished by a calcium
channel blocker, nifedipine, indicating a calcium dependent mechanism for the proliferation.
Methods: In the present study, we investigated the effect of APα on the regulation of intracellular
calcium concentration in E18 rat hippocampal neurons using ratiometric Fura2-AM imaging.
Results: Results indicate that APα rapidly increased intracellular calcium concentration in a dose-
dependent and developmentally regulated manner, with an EC50 of 110 ± 15 nM and a maximal
response occurring at three days in vitro. The stereoisomers 3β-hydroxy-5α-hydroxy-pregnan-20-
one, and 3β-hydroxy-5β-hydroxy-pregnan-20-one, as well as progesterone, were without
significant effect. APα-induced intracellular calcium concentration increase was not observed in
calcium depleted medium and was blocked in the presence of the broad spectrum calcium channel
blocker La3+, or the L-type calcium channel blocker nifedipine. Furthermore, the GABAA receptor
blockers bicuculline and picrotoxin abolished APα-induced intracellular calcium concentration rise.
Conclusion: Collectively, these data indicate that APα promotes a rapid, dose-dependent, stereo-
specific, and developmentally regulated increase of intracellular calcium concentration in rat
embryonic hippocampal neurons via a mechanism that requires both the GABAA receptor and L-
type calcium channel. These data suggest that APα-induced intracellular calcium concentration
increase serves as the initiation mechanism whereby APα promotes neurogenesis.
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Background
Allopregnanolone (APα; 3α-hydroxy-5α-hydroxy-preg-
nan-20-one; also known as tetrahydroprogesterone) is a
derivative of progesterone that is produced in both the
periphery and the central nervous system via enzymatic
conversions of progesterone [1-3]. In mature neurons,
APα is known to act as an allosteric modulator of the γ-
aminobutyric acid type A (GABAA) receptor, binding to a
specific site within the GABAA receptor at physiological
concentrations (6–35 nM) [4,5] to increase chloride
influx, thereby hyperpolarizing the neuronal membrane
potential, and decreasing neuron excitability [6-11]. In
marked contrast, the flux of chloride in developing neu-
rons is opposite to that of mature neurons. Because of the
high intracellular chloride content in immature neurons,
APα provokes an efflux of chloride through the GABAA
receptor, depolarization of the membrane, opening volt-
age dependent L-type calcium channels, leading to an
influx of calcium from the extracellular medium [12-16].
Calcium signalling plays a key role in neural function and
neural development [17-20]. Increases in intracellular cal-
cium concentration ([Ca2+]i) also control cell cycle pro-
tein expression and promote cell proliferation [21-26].
Therefore, GABAA receptor-mediated depolarization may
be the trigger that leads to activity-independent [Ca2+]i rise
in early precursor cells, or neural progenitors and stem
cells, and consequently may influence early developmen-
tal events, including neurogenesis and synaptogenesis
[16,27-29].
Previously we found that APα rapidly induced neurite
regression in cultured hippocampal neurons [30], which
we later identified as a prelude to entry into the cell cycle
and mitosis [29]. Recently, we demonstrated that APα reg-
ulates the expression of genes encoding cell cycle-related
molecules and enhances human cortical neural progeni-
tor, and rat hippocampal neuronal progenitor cell prolif-
eration  in vitro [29], and in vivo in triple transgenic
Alzheimer's disease mice dentate gyrus [31-33]. Moreover,
the L-type calcium blocker nifedipine abolished the APα-
induced cell proliferation. We therefore hypothesized that
the APα-induced neural progenitor cell proliferation is
mediated by calcium influx via GABAA receptor-activated
L-type calcium channels. To test this hypothesis, we inves-
tigated the impact of APα on calcium dynamics using
Fura2 fluorescent ratio calcium imaging in rat E18 hip-
pocampal neurons.
Methods
Animals and primary hippocampal neuron culture
Timed-pregnant Sprague-Dawley rats were purchased
from Harlan Sprague Dawley, Inc. (Indianapolis, IN,
USA). Rats were housed under controlled conditions of
temperature (22°C), humidity (30–50%), and light (14
hour light:10 hour dark); water and food were available
ad libitum. All experiments conformed to the Animal Wel-
fare Act, Guide to Use and Care of Laboratory Animals,
and the US Government Principles of the Utilization and
Care of Vertebrate Animals Used in Testing, Research, and
Training guidelines on the ethical use of animals. In addi-
tion, the minimal number of required animals was used
for these experiments and suffering was minimized. Pri-
mary cultures of dissociated hippocampal neurons were
performed as previously described [29,30]. Briefly, hip-
pocampi were dissected from the brains of E18 rat fetuses,
treated with 0.02% trypsin in Hank's balanced salt solu-
tion (HBSS, Invitrogen, Grand Island, NY, USA) for 5
minutes at 37°C and dissociated by repeated passage
through a series of constricted, fire-polished Pasteur
pipettes. Cells were plated onto poly-D-lysine-coated 22
mm diameter cover slips at a density of 2–4 × 104 cells per
cm2, and grown in Neurobasal medium without phenol
red (NBM; Gibco/Life Technologies, St. Petersburg, FL,
USA) supplemented with 2% B27 (Gibco/Life Technolo-
gies), 10 U/ml penicillin, 10 μg/ml streptomycin, 0.5 mM
glutamine and 25 μM glutamate. Cultures were main-
tained at 37°C in a humidified 5% CO2 atmosphere until
the day of imaging.
Steroids
All steroids used in this study were purchased from Ster-
aloids.Inc (Newport, Rhode Island, USA). They were: allo-
pregnanolone (APα; 5α-pregnan-3α-ol-20-one);
pregnanolone (3α5βAP; 5β-pregnan-3α-ol-20-one); epi-
pregnanolone (3β5βAP; 5β-pregnan-3β-ol-20-one); epial-
lopregnanolone (3β5αAP; 5α-pregnan-3β-ol-20-one);
and progesterone (P4; 4-pregnane-3,20-dione).
[Ca2+] microfluorimetry and imaging
[Ca2+] in hippocampal neurons was determined by ratio-
metric imaging of the Ca2+-sensitive fluorescent dye, Fura-
2 acetooxymethyl ester (Fura-2 AM, Molecular Probes,
Eugene, OR, USA), as previously described [34,35].
Briefly, cells were loaded with 2 μM Fura-2 AM in HEPES-
buffered solution (HBS; 100 mM NaCl, 2.0 mM KCl, 1.0
mM CaCl2, 1.0 mM MgCl2, 1.0 mM NaH2PO4, 4.2 mM
NaHCO3, 12.5 mM HEPES and 10.0 mM glucose, pH 7.4)
for 45 minutes at 37°C, 5% CO2. Cells were then washed
in HBS to remove excess Fura-2 AM and incubated in HBS
for another 30 minutes to equilibrate. The cover slip with
cells loaded with Fura-2 AM was then mounted in a per-
fusion chamber and placed on an inverted microscope
(Olympus IMT-2). Baseline [Ca2+] was obtained over 1
minute prior to the initiation of stimulus, which was
maintained for the duration of the imaging. Stimulation
was initiated by perfusion (2 ml/minute), or bolus addi-
tion (200 μl in total of 1,000 μl), to a static bath of the
indicated compounds. Fura-2 was successively excited by
a xenon light source at 340 nm and 380 nm by means ofBMC Neuroscience 2008, 9(Suppl 2):S11 http://www.biomedcentral.com/1471-2202/9/S2/S11
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two narrow beam band-pass filters selected by a compu-
ter-controlled filter wheel. The emitted fluorescence was
filtered through a 520 nm filter, captured with an intensi-
fied CCD camera (COHU, San Diego, CA, USA), and ana-
lyzed with InCyt Im2 software (Intracellular Imaging, Inc.,
Cincinnati, OH, USA). The [Ca2+] was calculated by com-
paring the ratio of fluorescence at 340 nm and 380 nm
against a standard curve. The curve was made from five
different [Ca2+] standards available from Molecular
Probes. Data from regions of interest were displayed in
real-time and logged to hard disk. Data are presented as
representative traces averaged from at least 10 cells per
experiment. Responses to treatments were quantified by
determining the difference between the average [Ca2+]i for
the period of time of maximal response during the drug
exposure and the average [Ca2+]i for 30 seconds prior to
exposure. Changes in [Ca2+]i are presented as mean ±
standard error of the mean (SEM) from three or more
independent experiments with ≥10 cells per experiment.
Statistical comparisons utilized one-way ANOVA fol-
lowed by Newman-Keul's post hoc analysis.
Results
APα induces a rapid and transient change in [Ca2+]i in 
hippocampal neurons
APα induced a rapid (within seconds) and transient (over
the course of minutes) increase in [Ca2+]i in E18 rat hip-
pocampal neurons (Figure 1A) as observed by ratiometric
imaging of the Ca2+-sensitive fluorescent dye Fura-2 AM
(Figure 1A). [Ca2+]i was calculated using a linear regres-
sion standard curve of the 340 nm/380 nm ratios of fluo-
rescence generated by a standard series of calcium
concentrations (Figure 1B). The multiple correlation coef-
ficient (R-square = 0.9942) indicated a linear relationship
between fluorescence ratio and [Ca2+]i (Figure 1B). Based
on this linear relationship, it was possible to generate an
approximate [Ca2+]i  value. Three distinct 'calcium
responses' in neurons exposed to APα emerged from this
analysis: high response, neurons exhibiting a ≥0.78 of 340
nm/380 nm ratio; low response, neurons exhibiting ≤0.73
of 340 nm/380 nm ratio; and no response (Figure 1C). In
the low response population, APα (250 nM) induced a
[Ca2+]i rise of 38 ± 2.6 nM, whereas in the high response
population, the same concentration of APα induced a
[Ca2+]i rise of 118 ± 32 nM (Figure 1D; p < 0.05 compared
to control neurons).
APα-induced [Ca2+]i rise is dependent upon dose and days 
in vitro and is stereoisomer specific
To characterize APα-induced [Ca2+]i signalling in embry-
onic hippocampal neurons, three issues were addressed:
dose-response; stereospecificity; and developmental pro-
file of response during days in vitro (DIV). Analysis for
dose-response and stereospecificity were conducted in
neurons at 3 DIV. Application of 10 nM APα showed an
insignificant increase in [Ca2+]i. A linear and significant
increase was observed from 50 nM, (13 ± 7 nM [Ca2+]i, p
< 0.05 versus vehicle control), and 100 nM APα (62 ± 12
[Ca2+]i, p < 0.01). Maximal response was observed when
250 nM APα was applied (135 ± 14 nM [Ca2+]i, p < 0.01),
which could not be further increased using 500–1,000 nM
APα (Figure 2A). The estimated EC50 value for APα was
124 ± 15 nM.
To determine the specificity of APα on the increase of
[Ca2+]i, the effects of several APα isomers, and its parent
molecule, progesterone, were compared at a concentra-
tion of 250 nM. APα induced an [Ca2+]i increase with an
average of 133 ± 11 nM. No significant [Ca2+]i response
was observed for 3β5αAP, 3β5βAP, or progesterone at the
same concentration. Only 3α5βAP induced a significant,
but lower, [Ca2+]i rise (73 ± 8 nM, p < 0.01; Figure 2B,C).
These data indicate that the APα-induced [Ca2+]i increase
is sterospecific for APα, and its 5β-, but not 3β-isomers.
To determine the proportion of hippocampal neurons
responsive to APα, and the duration of responsiveness,
the number of APα-induced [Ca2+]i-responsive neurons
were assessed each day for 11 days (216 neurons/day).
The percentage of APα-induced [Ca2+]i rise in neurons
increased linearly from day 0 to day 4 (DIV), followed by
a stepwise decrease in the number of neurons that, by day
11, had returned to day 0 levels (Figure 2D). At DIV 0, 25
± 5% of the neurons exhibited a APα-induced [Ca2+]i
increase; at DIV 1, 61 ± 7%; at DIV 2, 84 ± 4%. By DIV 3,
the number of APα-responding neurons reached an
asymptote at 90 ± 6% (Figure 2D; *p < 0.01 and **p <
0.001) and remained at that level until DIV 4. From DIV
7–10, the number of responding neurons declined and
remained stable at approximately 63%. By DIV 11, the
number of neurons responding to APα (30 ± 4%)
declined to the level observed at DIV 0.
Different types of [Ca2+]i responses
To determine the developmental profile for low and high
responders, we determined the change in the magnitude
of APα-induced [Ca2+]i in low and high responders, and
the portion of the population of responders across DIV.
We first investigated whether the magnitude of the APα-
induced [Ca2+]i  changed with time in culture. High-
response, low-response, and non-responsive neurons
were consistently observed from DIV 0 to DIV 11. As sum-
marized in Figure 3A, the magnitude of APα-induced
[Ca2+]i in low responders (340/380 nm fluorescence ratio
lower than 0.73 and reflect <45 nM increase in free cal-
cium; Figure 1B) showed no significant change during the
entire 11-day experimental period. In contrast, the magni-
tude of APα-induced [Ca2+]i in high-response neurons
(340/380 nm fluorescent ratio >0.78, reflecting a >65 nM
increase in free calcium, p < 0.01) increased from 65 toBMC Neuroscience 2008, 9(Suppl 2):S11 http://www.biomedcentral.com/1471-2202/9/S2/S11
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APα induces a rapid and transient [Ca2+]i rise in rat E18 hippocampal neurons in primary culture Figure 1
APα induces a rapid and transient [Ca2+]i rise in rat E18 hippocampal neurons in primary culture. Cells grown on glass cover 
slips were loaded with Fura-2 AM as described in the Methods. The [Ca2+]i was determined on single cells in HBSS medium. 
(A) Images represent calcium fluro-2 fluorescence in rat hippocampal neurons under vehicle control (top) and 500 nM APα 
(bottom). A fluorescent gradient of fluorescence ratio of 340 nm/380 nm is presented at the right side of the images. (B) A lin-
ear regression and the multiple correlation coefficient R-square value indicate the perfect correlation between fluorescence 
ratio of 340 nm/380 nm and [Ca2+]. (C) APα induced rapid and transient responses of [Ca2+]i recorded in a time course and 
expressed as the fluorescence ratio between 340 nm/380 nm, which is a representative of three different experiments. (D) Bar 
graph represents the summary of [Ca2+]i in response to control, vehicle control, and 500 nM APα. Data are mean ± SEM (*p 
< 0.05 compared to control neurons; N = 3 experiments with 36 neurons/condition/experiment). No changes in [Ca2+]i were 
observed under control or vehicle control conditions. With the addition of 500 nM APα, three types of calcium responses 
were observed in neurons: high (defined as an increase in [Ca2+]i >65 nM over the baseline); low (defined as an increase in 
[Ca2+]i <45 nM over the baseline); and no response (defined as neurons that did not show a measurable increase in [Ca2+]i over 
their baseline).BMC Neuroscience 2008, 9(Suppl 2):S11 http://www.biomedcentral.com/1471-2202/9/S2/S11
Page 5 of 10
(page number not for citation purposes)
125 ± 10 nM in the first 3 days, and reached a plateau for
the remaining days of culture. We then determined
whether the number of high-response neurons versus
low-response neurons changed during time in culture and
present the data as a percentage of total cells (Figure 3B;
*p < 0.01 and **p < 0.001). The number of high-response
neurons increased rapidly and linearly, and reached the
highest percentage of 65 ± 7% on DIV 3, gradually
decreasing to less than 40% on DIV 7. The number of low-
response neurons also increased early in the course of cul-
turing and reached the greatest percentage of 27 ± 5% on
DIV 2, decreasing to 17 ± 3% on DIV 3 (no significant dif-
ference with DIV 0). However, on DIV 4, the percentage of
low-response neurons returned to a level similar to that
observed on DIV 2 and then gradually decreased. DIV 3
was the time-point at which the highest number of high-
APα-induced [Ca2+]i rise shows dose- and DIV-dependent  manner and is stereoisomer-specific Figure 2
APα-induced [Ca2+]i rise shows dose- and DIV-dependent 
manner and is stereoisomer-specific. (A) Bar graph shows 
dose responses of APα on [Ca2+]i rise in 3 DIV neurons. 
Data are mean ± SEM (N = 3–6 experiments with 36 neu-
rons/condition/experiment, *p < 0.05, **p < 0.01). (B) Stere-
ospecificity of APα-induced [Ca2+]i. Neurons were exposed 
to 250 nM of the stereoisomers APα, 3α5βAP, 3β5αAP, 
3β5βAP or progesterone (250 nM) at the time-point indi-
cated by the arrow. The graph is a representative of four dif-
ferent experiments (N = 36 neurons/condition/experiment). 
(C) Bar graph shows the summary of data collected from 
stereoisomer experiments and represented as [Ca2+]i. **p < 
0.01 APα or 3α5βAP compared to control, or APα and 
3α5βAP compared to each other; N = 4 experiments with 
36 neurons/condition/experiment. (D) Bar graph indicates 
the percentage of neurons that exhibit a [Ca2+]i rise in 
response to 500 nM APα at different days in vitro (DIV). DIV 
0 is defined as the day the neurons are seeded. The greatest 
response, around 90% of cells responding to APα, is 
observed on 3 DIV. Data are mean ± SEM (N = 3 independ-
ent experiments with at least 36 neurons/condition/experi-
ment). *p < 0.01, **p < 0.001 versus DIV 0.
The magnitude of the APα-induced intracellular calcium  response changes at different DIV Figure 3
The magnitude of the APα-induced intracellular calcium 
response changes at different DIV. (A) Bar graph indicates 
the magnitude of the [Ca2+]i increases, high response 
(defined as >65 nM [Ca2+]i rise over the baseline) or low 
response (defined as <45 nM [Ca2+]i rise over baseline), in 
[Ca2+]i over the baseline in hippocampal neuron cultures at 
different DIV treated with 500 nM APα. (B) Bar graph indi-
cates the percentage of hippocampal neurons that respond 
to 500 nM APα with a high or a low response at different 
DIV. Data are mean ± SEM (N = 3 independent experiments 
with at least 36 neurons/condition/experiment). *p < 0.01, 
**p < 0.001 versus DIV 0.BMC Neuroscience 2008, 9(Suppl 2):S11 http://www.biomedcentral.com/1471-2202/9/S2/S11
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response neurons, and the lowest number of low-
response neurons, were observed. These data indicate that
the magnitude of calcium responses, and the numbers of
APα-induced [Ca2+]i-responsive neurons, vary with the
days of culture and that DIV 3 represents a pivotal time-
point in the response to APα.
APα-induced [Ca2+]i rise reflects an influx of extracellular 
Ca2+ and is regulated by an L-type calcium channel
Free [Ca2+]i increase could result from either an influx of
extracellular calcium or a release of calcium from an intra-
cellular pool stored in organelles, including the endoplas-
mic reticulum and mitochondria. To investigate whether
the APα-induced [Ca2+]i rise required an influx of extracel-
lular Ca2+, neurons at DIV 3–4, when 84% of neurons
should be responsive to APα (65% high responders), were
treated with 500 nM APα in a calcium-free medium. To
sustain comparable osmolarity and ionic strength, 2 mM
NaCl was substituted for 1 mM CaCl2. In the absence of
extracellular calcium, APα did not induce a rise in [Ca2+]i
(Figure 4A). This result suggested that the APα-induced
[Ca2+]i rise could be attributed mainly, if not completely,
to the influx of extracellular Ca2+. To discern which cal-
cium channel was required for the calcium influx, neu-
rons were exposed to the inorganic-calcium transport
inhibitor La3+ (10 μM) [36,37]. Exposure to La3+ reduced
the APα-induced [Ca2+]i rise from 78 ± 5 nM to 42 ± 7 nM
(Figure 4B; p < 0.05). When nifedipine, a more specific
blocker to L-type calcium channels was used, the APα-
induced [Ca2+]i rise decreased from 82 ± 14 nM to 20 ± 4
nM (Figure 4C; p < 0.01). These data indicate that the
APα-induced [Ca2+]i rise is dependent upon extracellular
Ca2+ and is regulated by the L-type calcium channel.
GABAA receptor mediates the [Ca2+]i rise induced by APα
It is well known that APα acts as an allosteric modulator
of the GABAA receptor/chloride channel by altering chlo-
ride flux and thereby hyperpolarizing (in mature neu-
rons) or depolarizing (in immature neurons) the
neuronal membrane [15,16,38-42]. To determine
whether the APα-induced [Ca2+]i  rise in hippocampal
neurons required the GABAA receptor, two GABAA recep-
tor blockers, picrotoxin (a non-competitive antagonist)
and bicuculline (the prototypical competitive antagonist
that directly competes with GABA for binding to the
receptor complex), were applied at 100 μM and 30 μM,
respectively. Both GABAAreceptor blockers completely
abolished the APα-induced [Ca2+]i  rise (Figure 5A,B).
These data indicate that the APα-induced [Ca2+]i  rise
requires activation of GABAA receptor and the L-type cal-
cium channel in rat hippocampal neuron cultures.
Discussion
Analyses using intracellular ratiometric Fura2 calcium
imaging demonstrated that APα specifically induced a
rapid, transient, and dose-dependent [Ca2+]i rise in E18 rat
hippocampal neurons in primary culture. The APα-
induced [Ca2+]i  rise was not observed in calcium-free
medium and was blocked by the L-type calcium channel
blockers La3+  and nifedipine. In addition, the GABAA
receptor inhibitors picrotoxin and bicuculline completely
abolished the APα-induced [Ca2+]i rise. These findings in
hippocampal neurons parallel those described by Daya-
nithi and Tapia-Arancibia [43] in fetal rat hypothalamic
neurons, suggesting that the APα-induced rise in [Ca2+]i is
a generalized effect in developing neurons.
The APα-induced rapid response in [Ca2+]i rise was spe-
cific to APα as the β-isomers of APα, namely 3β5βAP and
3β5αAP, and its parent molecule, progesterone, were
without effect, whereas 3α5βAP induced a [Ca2+]i rise that
was 50% of the effect of APα. These data suggest the struc-
ture with the most important impact on stereospecificity
may reside at the 3 position of the neurosteroid. Indeed,
both an extracellular application, and 3α-substitutions of
the A ring of the steroid nucleus, have been reported to be
prerequisites for many of the interactions of the neuroster-
oid with GABAA receptor/Cl- channels, because neither
intracellular applications, nor 3β-substituted steroids
applied extracellularly, show agonistic effects of GABA
[4,44,45]. Recent analyses by Hosie et al. [10] indicate that
APα can bind to two sites on the GABAA receptor, one that
potentiates, and one that directly activates the GABAA
receptor. The potentiating binding site of APα resides in a
cavity formed by the α-subunit transmembrane domains.
The direct activating binding site of APα located among
interfacial residues between the α and β subunits and is
enhanced by steroid binding to the potentiation site [10].
Data presented here demonstrate that the APα-induced
[Ca2+]i rise can be abolished by two GABAA receptor block-
ers, namely bicuculline [46-49] and picrotoxin [50-52],
strongly supporting the notion that the APα-induced
[Ca2+]i  rise is a GABAA receptor-mediated process and
most likely through the direct activating binding site.
GABAA receptor is an ion channel that allows either influx
or efflux of chloride ions (Cl-), depending upon the pre-
vailing transmembrane [Cl-] gradient. Because immature
neurons have a higher intracellular [Cl-], activation of the
GABAA receptor by GABA, or other agonists, for example,
muscimol, causes efflux of Cl- and thus membrane depo-
larization [15,53]. This depolarization is sufficient to
open L-type voltage-gated calcium channels, leading to
calcium influx [54-56]. GABA and GABA-induced calcium
influx have been linked to trophic actions important for
developmental processes, including the expression of
brain-derived neurotrophic factor [20]. Thus, GABAA
receptor-mediated depolarization may be the trigger for a
spontaneous, activity-independent [Ca2+]i  rise in early
precursor cells, or subventricular zone radial precursorBMC Neuroscience 2008, 9(Suppl 2):S11 http://www.biomedcentral.com/1471-2202/9/S2/S11
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cells, thereby influencing early developmental events,
including neurogenesis and synaptogenesis [16,28,29]. In
the present study, we have demonstrated that the APα-
induced [Ca2+]i rise can be blocked by a voltage-gated cal-
cium channel blocker, La3+, as well as a more specific L-
type calcium channel blocker, nifedipine. Further, we
recently demonstrated that the L-type calcium channel
blocker nifedipine specifically abolished the APα-induced
proliferation of rat hippocampal neuronal progenitor
cells [29]. Taken together, these data suggest that the APα-
induced [Ca2+]i rise, regulated by the L-type calcium chan-
nel and evoked by GABAA receptor, may be the signalling
initiation mechanism for APα-induced neuroprogenitor
cell proliferation and cell cycle gene expression.
APα-induced [Ca2+]i increases result from influx of extracellular calcium and are mediated by the L-type calcium channel Figure 4
APα-induced [Ca2+]i increases result from influx of extracellular calcium and are mediated by the L-type calcium channel. (A) 
Neurons (3–4 DIV) were exposed to 500 nM APα or vehicle control in Ca2+-free medium at the time-point indicated by the 
arrow. In the medium without calcium, APα showed no effect on intracellular calcium concentration. A representative graph of 
four independent experiments is shown (N = 36 neurons/condition/experiment). (B) La3+ diminished APα-induced [Ca2+]i 
rises. Neurons (3–4 DIV) were incubated with or without 10 μM La3+ (a calcium channel blocker) for 30 minutes prior to and 
continuously throughout imaging, and 500 nM APα or vehicle was added at the time-point indicated by the arrow. (B1) Repre-
sentative graph of three different experiments (N = 36 neurons/condition/experiment). (B2) Bar graph represents the sum-
mary of [Ca2+]i rise in response to control, 10 μM La3+, 500 nM APα, and APα + La3+. Data are mean ± SEM, *p < 0.05 
compared to APα treated neurons; N = 3 experiments with 36 neurons/condition/experiment. (C) Nifedipine blocked APα 
induced [Ca2+]i rises. Neurons were incubated with or without 10 μM nifedipine (an L-type calcium channel blocker) for 30 
minutes prior to and continuously throughout imaging, and 250 nM APα or vehicle was added at the time-point indicated by 
the arrow. (C1) The graph is representative of three different experiments (N = 36 neurons/condition/experiment). (C2) The 
bar graph represents quantitative changes in [Ca2+]i in response to control, 10 μM nifedipine, APα, and APα + 10 μM nifed-
ipine. Data are mean ± SEM (**p < 0.01 compared to APα treated neurons; N = 36 neurons/condition/experiment).BMC Neuroscience 2008, 9(Suppl 2):S11 http://www.biomedcentral.com/1471-2202/9/S2/S11
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As development progresses, the effect of APα associated
with GABAA  receptor binding gradually switches from
excitatory to inhibitory [15,16,57,58]. The timing of the
shift from depolarizing to hyperpolarizing via GABAA
receptor varies across brain regions, but is generally com-
plete by the second week of life in the rat and mouse
[12,59-61]. Remarkably, APα induction of [Ca2+]i rise in
cultured hippocampal neurons closely parallels the devel-
opmental time course of Na+-K+-2Cl-  co-transporter
expression [62,63]. In primary cultures of the E18 rat hip-
pocampal neurons, a mixture of E16–E18 neurons with
differing phenotypes will exist. Therefore, it is not surpris-
ing that high and low APα-induced calcium responses
were observed in this study. The high and low calcium
responses may be indicative of the developmental stage of
the neuron in culture.
The GABAA receptor is composed of a pentamer of struc-
turally homologous subunits that may be drawn from the
α1–6, β1–3, γ1–3, δ, ε, θ, ρ1–3, and π subunit families.
The precise subunit composition of different GABAA
receptor isoforms is an important determinant of their
pharmacological and biophysical properties [4,64-69],
but the exact combination heterogeneity exist. For exam-
ple, a study indicated that the subunit combinations com-
prising α1β1γ2 and α3β1γ2 required a three- to seven-fold
lower concentration for APα to enhance GABA-evoked
current to the same degree as other combinations [70],
while another study demonstrated that the potencies of
APα to enhance GABA response were significantly higher
in the α5β2γ2 receptor versus α1β2γ2 [71]. Another study
suggested that the efficacy of APα to enhance GABA
response depended on the γ subunit subtype: α1β1γ3 >
α1β1γ2 = α1β1γ1 [72]. Interestingly, during migration
from the subventricular zone to the cortical plate, neurons
became predominantly GABAergic, and their dominant
GABAA receptor subunit expression pattern changed from
α4β1γ1 to α3β3γ2 or α3β3γ3, coincident with an increas-
ing potency of GABA on GABAA receptor-mediated depo-
larization [73]. Although heterogeneity of the subunit
combination exists, all these studies suggest that the
effects of APα depend on subunit combinations of the
GABAA receptor and the combination is changing during
development. Therefore, the different GABAA  receptor
subunit combinations might be the underlying mecha-
nism for the variety of APα-induced [Ca2+]i responses in
cultured hippocampal neurons. Along with DIV, the com-
bination of the GABAA receptor subunits is changing and
a possible time-point at which one GABAA receptor subu-
nit combination switches to another is 3–4 DIV. However,
exact matching of neuronal high and low calcium
responses to the expression of specific GABAA receptor
subunit combinations, and investigation of the role of
each combination, needs to be further addressed.
Conclusion
These data demonstrate that APα induced a dose and
developmentally regulated rise in [Ca2+]i that was stere-
ospecific, rapid, and transient in E18 rat hippocampal
neurons in primary culture. Moreover, our data indicated
that the APα-induced rise in [Ca2+]irequires both GABAA
receptor and L-type calcium channel. Together with earlier
findings, we propose that the APα-induced rise in [Ca2+]i
provides a mechanism whereby APα can promote prolif-
eration of rodent, and also possible of human, neural pro-
genitor cells.
APα-induced [Ca2+]i rises are mediated by the GABAA recep- tor Figure 5
APα-induced [Ca2+]i rises are mediated by the GABAA recep-
tor. (A) Picrotoxin completely abolished APα-induced 
[Ca2+]i rises. Fluorescent Fura2-AM imaging of 3 DIV hippoc-
ampal neurons incubated with or without 100 mM picrotoxin 
(a non-competitive GABAA receptor antagonist) 30 minutes 
prior to and continuously throughout imaging. APα (500 nM) 
or vehicle was added at the time-point indicated by the 
arrow. The graph is representative of the four experiments 
conducted (N = 36 neurons/condition/experiment). (B) 
Bicuculline completely abolished APα-induced [Ca2+]i rises. 
Fluorescent Fura2-AM imaging of 3 DIV hippocampal neu-
rons incubated with or without 30 μM bicuculline (a compet-
itive GABAA receptor antagonist) for 30 minutes prior to and 
continuously throughout imaging. APα (500 nM) or vehicle 
was added at the time-point indicated by the arrow. The 
graph is representative of the four different experiments 
conducted (N = 36 neurons/condition/experiment).BMC Neuroscience 2008, 9(Suppl 2):S11 http://www.biomedcentral.com/1471-2202/9/S2/S11
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